MEDWISE

Tabula Rasa Healthcare, Inc.

Application Filed: 2018-07-26
Trademark Application Details
Trademark Logo MEDWISE

Mark For: MEDWISE® trademark registration is intended to cover the category of drug utilization review services. [all]

Status

2021-07-09 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88054410
Registration Number6024887
Mark Literal ElementsMEDWISE
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeSERVICE MARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-02-22
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
  • 102: Insurance and Financial
Primary International Class
  • 035 - Primary Class
  • (Advertising and business) Advertising; business management; business administration; office functions.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSeth A. Rappaport
Attorney Docket Number000929.0031
Law Office AssignedM50
Employee NameNEVILLE, JAMES B

Timeline

2018-07-26Application Filed
2018-07-26Date of First Use
2018-07-26Date of Use In Commerce
2018-11-26Location: PUBLICATION AND ISSUE SECTION
2019-01-01Published
2019-01-01Published for Opposition
2019-01-01Status: Live/Pending
2019-01-01Transaction Date
2020-02-22Location: PUBLICATION AND ISSUE SECTION
2020-03-31Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2020-03-31Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Tabula Rasa Healthcare, Inc.
Address228 Strawbridge Drive Moorestown, NEW JERSEY UNITED STATES 08057
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

SETH A. RAPPAPORT
MORGAN, LEWIS & BOCKIUS LLP
1111 PENNSYLVANIA AVENUE, NW
ATTN: TMSU
WASHINGTON, DC 20004

Good, Services, and Codes


IC 035. US 100 101 102. G & S: drug utilization review services. FIRST USE: 20180726. FIRST USE IN COMMERCE: 20180726

International Codes:35
U.S. Codes:100,101,102
International Codes:45
U.S. Codes:100,101
Type CodeType
PM0001MED WISE
GS0351drug utilization review services

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2020-03-31
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2020-02-25
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2020-02-22
STATEMENT OF USE PROCESSING COMPLETE2020-02-0766230
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-02-0666230
USE AMENDMENT FILED2020-01-2166230
TEAS STATEMENT OF USE RECEIVED2020-01-21
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-08-24
TEAS EXTENSION RECEIVED2019-08-22
EXTENSION 1 GRANTED2019-08-2298765
EXTENSION 1 FILED2019-08-2298765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-02-26
PUBLISHED FOR OPPOSITION2019-01-01
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-01-01
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-12-12
APPROVED FOR PUB - PRINCIPAL REGISTER2018-11-20
ASSIGNED TO EXAMINER2018-11-1376737
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-08-01
NEW APPLICATION ENTERED IN TRAM2018-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed